Contract Pharma Staff12.01.20
Spanish contract development and manufacturing organization (CDMO) Idifarma has entered a partnership with Stefano Console from Swiss life sciences consultancy Oriento SA.
Bringing with him the benefit of over 25 years of experience in the pharmaceutical and fine chemical industry, Console will be Idifarma’s scientific advisor focusing upon spray drying technology and particle engineering.
Stefano Console joins CDMO Idifarma as scientific advisor.
“Stefano is a very experienced professional with an extensive technical background combined with a great business acumen that will benefit Idifarma and our clients enormously,” said Alfredo Gómez, head of site, Idifarma. “This partnership will bring together Stefano's knowledge and experience in particle engineering, particularly in amorphous solid dispersions and dry powders for inhalation, and Idifarma's highly skilled staff and specialized capabilities to better serve and grow our client base and strengthen our position as one of the leading providers of spray drying services for niche and potent drugs.”
Console joins Idifarma as scientific advisor, with his experience gathered from CDMOs in Italy and Switzerland and strategic roles managing many successful projects for pharma partners across the EU, U.S. and Japan.
Idifarma is a CDMO for niche and highly potent drugs, focusing in oral solids for oncology, and with special capabilities such as spray-drying at its 40,000 square foot facilities.
Bringing with him the benefit of over 25 years of experience in the pharmaceutical and fine chemical industry, Console will be Idifarma’s scientific advisor focusing upon spray drying technology and particle engineering.
Stefano Console joins CDMO Idifarma as scientific advisor.
Console joins Idifarma as scientific advisor, with his experience gathered from CDMOs in Italy and Switzerland and strategic roles managing many successful projects for pharma partners across the EU, U.S. and Japan.
Idifarma is a CDMO for niche and highly potent drugs, focusing in oral solids for oncology, and with special capabilities such as spray-drying at its 40,000 square foot facilities.
